TABLE OF CONTENTS
Volume 11, Issue 4 (July 2005)
Editorial
Editorial: Moving beyond metaphors: University-industry collaboration in biotechnology
Michael J Lynskey
J Commer Biotechnol 11: 301-304; doi:10.1057/palgrave.jcb.3040130
Papers
Commercialisation and spin-out activities of the Institute of Biotechnology
Christopher R Lowe
J Commer Biotechnol 11: 305-317; doi:10.1057/palgrave.jcb.3040131
Stanford's licensing and equity practices with biotechnology companies
Kirsten Leute
J Commer Biotechnol 11: 318-324; doi:10.1057/palgrave.jcb.3040132
How DanioLabs has evolved its relationship with the CIMR
Paul Goldsmith and Derek Jones
J Commer Biotechnol 11: 325-329; doi:10.1057/palgrave.jcb.3040133
The role of research institutions in the formation of the biotech cluster in Massachusetts: The MIT experience
Lita L Nelsen
J Commer Biotechnol 11: 330-336; doi:10.1057/palgrave.jcb.3040134
The evolving concept of value add in university commercialisation
Alison F Campbell
J Commer Biotechnol 11: 337-345; doi:10.1057/palgrave.jcb.3040135
Current topics in biotechnology patent law: The written description requirement
Benjamin A Adler
J Commer Biotechnol 11: 346-352; doi:10.1057/palgrave.jcb.3040136
How academics can make (extra) money out of their science
William Bains
J Commer Biotechnol 11: 353-363; doi:10.1057/palgrave.jcb.3040137
Kinik: Raising the stakes for importing products derived from US patented processes practised abroad
Scott B Familant
J Commer Biotechnol 11: 364-368; doi:10.1057/palgrave.jcb.3040138
Trends underlying early-stage drug discovery and development collaborations from October 2002 to September 2004
Mark J Belsey and Alex K Pavlou BSc, MSc, PhD
J Commer Biotechnol 11: 369-373; doi:10.1057/palgrave.jcb.3040139
Miscellaneous
Legal and regulatory update: Legal and regulatory update
John Wilkinson and Frederick J Dorey
J Commer Biotechnol 11: 374-386; doi:10.1057/palgrave.jcb.3040140
